RAMOS RAMIREZ, MARITZA

RAMOS RAMIREZ, MARITZA

CIENCIAS MÉDICAS · Nivel C

en INSTITUTO NACIONAL DE CANCEROLOGIA

Información*

Nombre MARITZA RAMOS RAMIREZ
Área MEDICINA Y CIENCIAS DE LA SALUD
Campo CIENCIAS MÉDICAS
Disciplina CIENCIAS CLÍNICAS
Especialidad PREVENCION
CVU 968916
Institución
Dependencia DIVISION MEDICA
Entidad CIUDAD DE MEXICO
Nivel C
Vigencia Inicio: 01/01/2023
Fin: 31/12/2026

* Información del primer trimestre de 2026.
Fuente: SECIHTI.

Publicaciones ORCID

2025
Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy Cancer and Metastasis Reviews
2023
Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes Clinical and Translational Oncology
Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial International Journal of Radiation Oncology*Biology*Physics
A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition International Journal of Molecular Sciences
Re‐irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index Cancer Medicine
2022
LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer Current Oncology
A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population Lung Cancer
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP) Lung Cancer
2021
Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies The Oncologist
The Evolution of Clinically Aggressive Triple-Negative Breast Cancer Shows a Large Mutational Diversity and Early Metastasis to Lymph Nodes Cancers